Efficacy and safety of levothyroxine monotherapy in lowering the risk of cardiovascular disease in older adults with subclinical hypothyroidism: research protocols of a multicenter, open-label, randomized controlled trial
ClinicalTrials.gov, No. ChiCTR2400092634. Registered on 30 November 2024. Recruitment for this study began on December 1, 2024, and continues until at least until November 30, 2025.
Authors
- Chong‐Rui Xu (ORCID: https://orcid.org/0000-0002-3474-2809)
- Hui Zhou (ORCID: https://orcid.org/0000-0002-8349-2869)
- Shuhang Xu (ORCID: https://orcid.org/0000-0002-8619-5376)
- Xiaofan Lu (ORCID: https://orcid.org/0000-0002-0272-0242)
- Yu Sun (ORCID: https://orcid.org/0000-0001-7636-8854)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Trials
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1186/s13063-025-08857-z
- Citations
- 2
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59